Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study

Colleen Lowry(Brigham and Women's Hospital), Lindsey R. Baden(Brigham and Women's Hospital), Sara O. Vargas(Harvard University Press), Karen Fiumara, Aaron Deykin(Biogen (United States)), J.T. Lee(Brigham and Women's Hospital), Francisco M. Marty(Brigham and Women's Hospital)

Transplant Infectious Disease

April 25, 2007

Cited by 82

|New England Journal of Medicine|2020|1.4k

|Science|2022|1.2k

|New England Journal of Medicine|2017|1.2k

|Clinical Infectious Diseases|2020|1.1k

|Nature Communications|2020|981

Related Papers